Jälgige meid
EE
EE

Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Kõik uudised

Arhiiv

✕
9 veebruar 2018
5382
HIV prevention drug Truvada to be publicly funded in New Zealand

HIV prevention drug Truvada to be publicly funded in New Zealand

Pharmac estimates up to 4,000 people with a high risk of contracting HIV will be eligible for a drug to prevent infection with the virus which the Government's drug buying agency will now fund. New Zealand will be one of the first countries in the world to publicly fund ...
9 veebruar 2018
5215
Kenneth Cole Steps Down as amfAR Chairman

Kenneth Cole Steps Down as amfAR Chairman

Kenneth Cole is stepping down as amfAR chairman, the designer announced Wednesday night at the charity's annual gala in New York.
9 veebruar 2018
5477
Ukraine Expands Opioid Substitution Therapy to Reduce HIV

Ukraine Expands Opioid Substitution Therapy to Reduce HIV

The Ukrainian government is increasing the scope of the country’s state-funded opioid substitution therapy programme – a harm reduction tool which reduces the risk of overdose and disease transmission.
8 veebruar 2018
5117
Scientists report big improvements in HIV vaccine production

Scientists report big improvements in HIV vaccine production

Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested.
8 veebruar 2018
7807
FDA Approves Gilead’s Biktarvy for Treatment of HIV

FDA Approves Gilead’s Biktarvy for Treatment of HIV

Food and Drug Administration has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet regimen for the treatment of HIV-1 infection.
7 veebruar 2018
4973
New data helps prioritise groups for HIV treatment

New data helps prioritise groups for HIV treatment

People aged 50 or over, individuals with low CD4 to CD8 ratios, and those with high viral loads are the groups that benefit the most from immediate antiretroviral treatment.
7 veebruar 2018
5629
New insight into how some viruses establish a chronic infection

New insight into how some viruses establish a chronic infection

The previously undiscovered molecular mechanism explains how certain viruses, including HIV and hepatitis C, can actively make immune cells less functional, allowing an infection to spread ahead of the body's immune response.
6 veebruar 2018
8120
Persian shallot could help fight TB antibiotic resistance

Persian shallot could help fight TB antibiotic resistance

A type of onion could help the fight against antibiotic resistance in cases of tuberculosis, a study has suggested.
6 veebruar 2018
8692
Mobile app for free condoms launched in the Philippines

Mobile app for free condoms launched in the Philippines

To tackle low condom use, activists have teamed up with restaurants and shops to set up dispensers with free condoms in the capital Manila which users can locate through an app.
5 veebruar 2018
5804
Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

Mortality in HIV-Infected Children Predicted by Urine TB Lipoarabinomannan

According to the study authors, HIV-infected hospitalized children initiating antiretroviral therapy are part of “a group in which tuberculosis diagnosis is often missed, and in whom early tuberculosis treatment is lifesaving.”
Kasutusmugavuse parendamiseks rakendab veebileht küpsiseid.
Lehel mis tahes nuppu klõpsates nõustute küpsiste kasutamisega.